Biote (BTMD) Revenue (2021 - 2026)

Biote's Revenue history runs 6 years deep, the most recent figure standing at $44.9 million for Q1 2026.

• In Q1 2026, Revenue fell 8.28% year-over-year to $44.9 million; the TTM figure through Mar 2026 stood at $188.2 million (down 5.63% YoY), while the FY2025 annual figure was $192.2 million, down 2.52% from the prior year.
• Revenue for Q1 2026 stood at $44.9 million, down from $46.4 million in the prior quarter.
• The five-year high for Revenue was $51.4 million in Q3 2024, with the low at $37.1 million in Q1 2022.
• The 5-year median for Revenue is $46.4 million (2025), against an average of $46.2 million.
• The sharpest annual moves came in 2023 and 2026: Revenue climbed 20.73% in 2023, then decreased 8.28% in 2026.
• Biote's Revenue stood at $44.5 million in 2022, then advanced by 2.74% to $45.7 million in 2023, then increased by 9.04% to $49.8 million in 2024, then declined by 6.87% to $46.4 million in 2025, then retreated by 3.17% to $44.9 million in 2026.
• Business Quant data shows BTMD's Revenue at $44.9 million in Q1 2026, $46.4 million in Q4 2025, and $48.0 million in Q3 2025.